Designed to improve GI tolerance and increase nutritional intake in patients with impaired GI function.
Introducing Peptisip Energy HP
Heavy on protein, light on the gut
Peptisip Energy HP is a high energy, high protein peptide-based 200ml Oral Nutritional Supplement (ONS). Designed to improve GI tolerance and increase nutritional intake in patients with impaired GI function.
Up to 45% of patients with GI disorders are at risk of malnutrition.1,2
Malnutrition is state of nutrition in which a deficiency of energy, protein, and other nutrients causes adverse effects on the body's size, composition and function resulting in poorer clinical outcomes.3
Why are patients with GI disorders at higher risk of malnutrition?
Patients with GI disorders can present with several symptoms such as diarrhoea, bloating, abdominal pain and vomiting6.
If symptoms are improperly managed, this may lead to:
Nutritional support is vital for patients with GI disorders, as emphasised in several ESPEN guidelines.4,5
Tolerance to formulations containing whole protein and fats is often poor in patients with GI disorders.6,7
In patients with GI disorders, when absorption and digestion of nutrients is impaired, peptide-based feeds have been shown to improve tolerance.6,7
* Medium chain triglycerides.
** Helps minimise electrolyte losses that occur in patients with GI intolerance symptoms.
† Helps meet Vitamin D requirements in patients with impaired GI function who are at risk of Vitamin D insufficiency and deficiency.
†† Lactose level below 300mg/kg
‡ Certified by the Halal Food Council of Europe.
‡‡ Nutricia has Kosher approval for this product.
Patient compliance to Peptisip Energy HP was 18% higher than with the prescribed baseline* ONS7. Increased compliance led to improved nutritional intake:7
* Prior to commencing the study patients were taking a different oral nutritional supplement.
** A p-value of <0.05 is statistically significant.
Peptisip Energy HP reduced the incidence and intensity of 7 out of 8 key GI symptoms.7
† A p-value of ≤0.05 is statistically significant.
Peptisip Energy HP has been studied7 in a variety of patients with complex conditions requiring a peptide-based ONS. Results from four of these patients have been collated in a series of clinical case studies, which are presented in this booklet. The case studies are intended to help educate healthcare professionals about the role of Peptisip Energy HP and offer practical guidance on its use in managing patients with GI intolerance symptoms.
Don't just take our word for it: see what Patient's had to say about Peptisip Energy HP during its clinical trial.7
Peptisip Energy HP was well accepted by trial participants7
Try Peptisip for yourself: Order a free sample±
± Product can be provided to patients upon the request of a healthcare professional. They are intended for the purpose of professional evaluation only
- Meijers J.M., Schol J.M., van Bokhorst-de van der Schueren M.A., et al. (2009) Malnutrition prevalence in The Netherlands: results of the annual Dutcnational prevalence measurement of care problems. Br J Nutr., 101(3), pp. 417-23.
- Russell C. and Elia M. (2012) Nutrition screening week in the UK and Republic of Ireland 2011. Hospitals care homes and mental health units [pdf]. BAPEN. Available from: nsw-2011-report.pdf (bapen.org.uk) [Accessed on : August 2021].
- Stratton R, Smith T, Gabe S. 2018 Managing malnutrition to improve lives and save money [pdf]. BAPEN. Available from: bapen.org.uk/pdfs/reports/mag/managingmalnutrition. pdf [Accessed: May 2022].
- Pironi L., Arends J., Bozzetti F., et al (2017) ESPEN guidelines on chronic intestinal failure in adults. Clin Nutr., 36(2), pp.247-307.
- Forbes A., Eschere J., Herbuterne X. et al. (2017) ESPEN guidelines: Clinical nutrition in inflammatory bowel disease. Clin Nutr., 26(2), pp.321-47.
- Alexander D.D., Bylsma L.C., Elkayam L, et al. (2006) Nutritional and health benefits of semi elemental diets: A comprehensive summary of the literature. World J gastrointest Pharmacol Ther., 7(2), pp. 306-19.
- Nutricia ACBS trial, data on file 2022.
- Arvanitakis M., Ockenga J., et al. (2020) ESPEN guidelines: Clinical nutrition in acute and chronic pancreatitis. Clin Nutr., 39(3), pp.612-631.
All products mentioned are Foods for Special Medical Purposes for the dietary management of disease related malnutrition and must be used under medical supervision
You may also be interested in
Completed
Breaking Down Peptide-Based Feeds: Who, Why, and When to Use
Recorded webinars & presentations
Tube Feeding
41 mins
Completed
Nutrition support post ICU: Guidance on continuing nutrition from ICU to recovery
Recorded webinars & presentations
Tube Feeding
82 mins
Completed
High protein nutritional support - more important than energy?
Articles
Frailty & Disease Related Malnutrition
20 mins
